Lonza
Hyderabad
Lonza is a global contract development and manufacturing organization (CDMO) that offers end‑to‑end solutions for pharmaceutical and biotech companies. Through its Integrated Biologics platform, Lonza provides gene‑expression systems, cell‑line development, and DNA‑to‑IND programs for antibodies, bispecifics, and recombinant proteins. Its Small‑Molecule services cover early‑phase synthesis, API manufacturing, formulation, and high‑throughput experimentation. The company also specializes in advanced modalities such as ADCs, cell and gene therapies, viral vectors, and mRNA/LNP products, delivering cGMP manufacturing, process development, and analytical support. With a focus on early derisking, developability assessment, and regulatory affairs, Lonza enables partners to accelerate drug discovery, development, and commercial launch across a broad therapeutic landscape.